India strengthens pharma regulation in 2025 with WHO benchmarking, ONDLS solvent tracking, QR codes on critical drugs, and anti-dumping probes to boost safety and compliance.
In 2025, India’s pharmaceutical sector is demonstrating remarkable dynamism, driven by a blend of global collaborations and homegrown innovation.
India pharma partnerships in 2025 are accelerating innovation, patient care, digital transformation, and market leadership through strategic alliances across R&D, tech, and supply chains.
Industry leaders share how AI, GCCs, local manufacturing, and quality-first strategies are reshaping India’s life sciences, biometrics, medical devices, and lab solutions ecosystem.